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Dencephalopathy, all study subjects underwent research pro-
tocol brain magnetic resonance imaging shortly after birth,
and a seizure burden index was generated.28 Full-scale IQ
was assessed at the age of 4 years in 77 survivors. After ad-
justment for the extent of anatomic injury detected by the
magnetic resonance images, Full-Scale IQ was significantly
depressed, with higher seizure burdens. The results of the
current study are consistent with the hypothesis that sei-
zures per se are independently associated with some ad-
verse developmental outcomes. In the BCAS, untreated
EEG seizures were associated with greater ND impairments
than found in the current study. The question must be asked
whether all or most infants undergoing infant heart surgery
should undergo long-term EEG monitoring to facilitate the
prompt detection and early treatment of seizures. Indeed,
such a recommendation has recently been made by the
American Clinical Neurophysiology Society.4
There are several limitations to the current study. Al-
though it is a large overall cohort, the number of patients
with EEG seizures is fortunately small. Seizures were
treated whenever identified; however, the therapies were
not standardized. In addition, the study was not designed
or powered to determine if early identification of a seizure
and institution of appropriate therapy would improve out-
comes. Finally, patterns of developmental disability change
as children develop; re-evaluation at an older age may iden-
tify additional deficits.
In summary, we found that the occurrence of a postoper-
ative EEG seizure after cardiac surgery in neonates and in-
fants was not associated with deficits in cognitive, language,
and motor skills. There is an association with impaired so-
cial interactions/restricted behavior and executive function
at 4 years of age. The adverse effect of a seizure on ND out-
comes may be less than identified in previous studies.
Prompt identification and treatment of postoperative sei-
zures may prevent secondary CNS injury due to ongoing
seizure activity. A clinical trial is indicated to determine if
EEG monitoring and targeted therapy of postoperative sei-
zures will improve ND outcomes.References
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Dr V. Mohan Reddy (Stanford, Calif). I would like to congrat-
ulate Bill and his colleagues for their important contribution to the
field of neurodevelopmental outcome after cardiac surgery. Your
institution has been prolific in this area and it is welcome to all
of us.rdiovascular Surgery c Volume 146, Number 1 137
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DThis study confirms that seizures in the perioperative period, es-
pecially electrical seizures, are important biomarkers of brain in-
jury, probably also clinical as well as from previous studies.
Whether seizures contribute to further injury to an already injured
brain is unclear, but evidence suggests they do. Perhaps, detection
and treatment are important to prevent further neurologic damage
from seizures, as shown by your study.
The questions I have:
Although for the whole cohort there were differences in func-
tion, executive and social functions, for seizure and no seizure ac-
tivity patients, there were no differences in hypoplastic subgroup
patients. How do you explain it?
Dr Gaynor. There were only 39 patients with hypoplastic left
heart syndrome who were monitored. In the whole cohort, there
were 14 patients with seizures who returned for evaluation. We
are underpowered for many subanalyses. I would imagine that if
we had more patients with hypoplastic left heart syndrome we
would probably see a similar pattern.
Dr Reddy. But the incidence of seizures was higher in the hy-
poplastic group.
Dr Gaynor. Yes. But again, it is still just a small number of
patients.
Dr Reddy. The second question is: The seizures in your manu-
script were classified as frontal versus nonfrontal seizures. Did you
analyze to see if there were any differences between the two?
Dr Gaynor. Again, in the Boston study they tend to find a trend
towards worse outcome with the frontal seizures. And when we
looked at that at 1 year, there was a trend.
We tried to look at it here again. With only 14 patients with sei-
zures, there simply was not enough power.
Dr Reddy. In looking at your data, it appears that if the circu-
latory arrest duration was less than 25 minutes, there were no in-
cidents of seizures. Would you in this light consider limiting the
arrest time to 25 whenever possible or avoiding altogether?
Dr Gaynor.Well, again, I think we did see seizures in the chil-
dren who had continuous bypass and, as I said, I think the paper
from Melbourne and Auckland that was recently published with
antegrade cerebral perfusion, where they had a 33% incidence of
seizures overall in the Norwood population, which was signifi-
cantly greater than what we have seen. And they actually had intra-
operative seizures.
Again, I think this needs to be studied prospectively, but that pa-
per would suggest that the use of antegrade cerebral perfusion
would not be protective. Perhaps a technique such as Christian Pi-
zarro and Ross Ungerleider have popularized, intermittent perfu-
sion, may be useful. Again, these we can speculate but need to
test the hypothesis.
Dr Reddy. I agree. I think antegrade cerebral perfusion is not
fully evaluated. But that study you mentioned was done at moder-
ate hypothermia. And in the laboratory we found that antegrade ce-
rebral perfusion is better performed at the same temperature as
deep hypothermic circulatory arrest rather than at higher
temperatures.
Dr Gaynor. Well, the temperatures between the 2 institutions
varied. One used 21 and one used 25, but they did not find any
difference between the institutions in the incidence of seizures.
So I think, I agree, and I am concerned about antegrade cerebral
perfusion at normothermia. I thinkwe have to be careful about that.138 The Journal of Thoracic and Cardiovascular SurgDr Reddy. I agree. At least in the laboratory it appears to us that
antegrade cerebral perfusion is best performed at deep hypother-
mic temperatures.
Dr Gaynor. Right.
DrReddy.Given the data, it seems that EEGmonitoring should
be mandatory in all our patients, although in the last couple slides
you mentioned it. Do we as a Society make it mandatory and have
our own recommendations?
DrGaynor.Well, again, whenwe did our systematic review, we
could not find any evidence, any class 1 evidence, that EEG mon-
itoring improved outcomes. Like I said, I would like to use this as
speculation. I do not want to make a formal recommendation that
you should use it. But I think it should clearly be a topic of study
and of something we look for going forward.
We were talking to our neurologists and our intensive care phy-
sicians about beginning to use this. And we did full 10-lead EEGs,
which a lot of the parents do not like because they leave the marks
on the head and it’s a big bandage. We need to learn if there are
other types of EEG monitoring, such as amplitude-integrated
EEG or something else to pick up seizures that may be sort of
less invasive and more acceptable to our ICU. But, yes, I think
this is potentially a modifiable factor that we could use to improve
outcomes.
Dr Reddy. Bill, congratulations again for all your group’s
efforts.
Dr Charles Fraser (Houston, Tex). I just want to comment. It is
a great subject that we will be debating, it sounds like, for the next
century.
About the comment you made about the antegrade cerebral per-
fusion, Bill, you know that from our data we did not see these and
we continuously monitor our patients postoperatively. We did not
see a high incidence of seizures as you describe in your comments.
So I think one of the problems about discussing these various stud-
ies is a lot of times you are comparing apples to oranges.
Dr Gaynor. The most important difference in your study com-
pared to the other studies, and I’ve actually talked to Dean about
this, is the kids were on continuous midazolam infusions. In prep-
aration for a grant, we have compared the anesthetic agents used
for stage I reconstruction across institutions. And the highest doses
of benzodiazepines are from Texas Children’s. In the paper, Dean
speculated that the use of continuous midazolam intraoperatively
and postoperatively may have masked seizures. If you are treating
already–it may improve outcomes. It may be that we find out that
the best thing we can do is to have them on midazolam and sup-
press any seizures. I do not know. But I think the data from Texas
Children’s is hard to interpret because theywere treated with a con-
tinuous midazolam infusion.
Dr Fraser. So my question is the dichotomy of statements. So
the last slide that you presented was a policy statement from
a learned society based on clearly not level 1 evidence.
Dr Gaynor. Exactly.
Dr Fraser. But in the same dialogue we’re having, we’re agree-
ing or disagreeing about acting on lack of level 1 evidence for other
measures. I am increasingly confused about what we should treat
and what we should not treat.
Dr Gaynor. Well, again, as am I. And I mean, we all, for any-
thing we do, we have to interpret the best evidence we can and
come up with a clinical practice that we use in our institution.ery c July 2013
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I think we need to begin to look at all these things that we do and
wherever possible try as a Society to develop the trials to actually
get the evidence and understand: Is there value added to these
strategies?
If you add 48-hour EEG monitoring, you have actually added
a lot of cost because of the interpretation, the machines. The techs
are always coming in the middle of the night because the leads
have fallen off. Is that cost-effective? I think it might be. But it
is something we need to test.
So, I think each of our institutions, as physicians, we have
looked at the available evidence, used our clinical experience
to come up with what is the best practice for our institution,
but it is hard to come up with broad standard-of-care decisions.
That is why my slide was titled ‘‘Speculation,’’ and it had
a hypothesis. And I think we need to obtain that evidence. So
I would not recommend a policy unless you are actually collect-
ing the data.
DrRichardGates (Orange, Calif). I am a bit confused, you just
told us a little while ago that you perfused neonates with transpo-
sition at 32. Why are you comfortable doing that and so worried
about perfusing a hypoplast at 32?
Dr Gaynor. You’re talking about perfusing through antegrade
cerebral perfusion?
Dr Gates. Right.
Dr Gaynor. Well, if you can show me the data that the neuro-
developmental outcomes are superior and that unlike the Mel-
bourne data, where they perfused at 25, they had a 33%
incidence of seizures, I could consider it. It is a hypothesis, we
can look and see, measure the data.
Dr Gates. But in a neonatal ECMO patient (neck-neck) you are
doing selective ipsilateral cerebral perfusion at normothermia. You
are also doing nonselective antegrade cerebral perfusion during
your transposition patient at 32. What is the difference between
doing it in a hypoplast?
Dr Gaynor. Well, there can be circle of Willis issues. We
know that there is a difference between cerebral hemisphere per-
fusion when you use antegrade. We know that there are differ-
ences based on flow rates, pressure, other variables. It may be.
They are testable hypotheses. I mean, again, there is not class
1 evidence for a lot of the things we do. And what I am trying
to avoid to do is making blanket statements that people canThe Journal of Thoracic and Cainterpret as standard of care. I am saying these are things that
need to be investigated.
Mohan just suggested that their animal experience suggests that
antegrade cerebral perfusion at normothermia is dangerous. Ani-
mal experiments do not always translate to clinical experience. I
think if we are going to use these techniques, we have a moral
and ethical obligation to measure the outcomes and report the out-
comes and show whether they are the same, better, not inferior. I
think that is what we have to do. So it is hard if we do not have
some data on that. As I said, we would not know about the seizures
unless you measured the seizures. Just because they do not have
a clinical seizure does not mean they are not seizing. We have to
get the data.
DrGates. I agreewith you that a clinical trial to comparemildly
hypothermic versus deep hypothermic selective cerebral perfusion
in neonates would be a great prospective study.
DrYves d’Udekem (Victoria, Australia). This ismore of a com-
ment, because it has been repeatedly mentioned that the patients in
Melbourne were seizing so much, that I just want to clarify a little
bit what we did after we found such a horrific rate of seizures in our
patients. We looked back at the data of the patients included in this
study with the perfusionists. The way we calculated the flow dur-
ing the original antegrade cerebral perfusion was keeping that flow
at a fixed percentage of the estimated cardiac output. And we were
seemingly maintaining flows in some of these patients at a percent-
age around 40%-50%. After that study, we kept doing antegrade
cerebral perfusions, we just increased the flow we were giving.
Sowe are now giving blood both to the brain and to the descending
aorta and we maintain flows around 70%-80%. And unfortunately,
because the research has now been concluded, we no longer have
EEG monitoring.
Dr Gaynor. But it would be nice, since you have changed your
practice, it would be important to measure that.
Dr Reddy. I think it is important, as I said, how much you flow
and what the perfusion pressure is when you do antegrade cerebral
perfusion is extremely important. We found in the animal experi-
ments that if your perfusion pressure is higher or if you are flowing
a higher flow than required, then you significantly see, at least we
saw, hemorrhage in the brain in a significant number of animals. So
I think the strategy of antegrade cerebral perfusion is not standard-
ized. We really do not know how much we should put flow and at
what pressure we should flow.rdiovascular Surgery c Volume 146, Number 1 139
